Billionaire Profile
Cai Hongbin
Global Rank
#3286

Image: Unsplash Contributor | Unsplash License | via Unsplash

Cai Hongbin

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$1.085B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
0% (24h)
Age
0
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

Cai Hongbin is a Chinese businessman and academic. As of March 2026, he is ranked #3185 on Forbes' Billionaires list, with a net worth of $1.1 billion, primarily derived from his stake in Jiangsu Hengrui Medicine, one of China's largest pharmaceutical companies. He is the Dean of the HKU Business School and Chair of Economics. Cai is also a member of the National People's Congress and has held positions as an independent director on several boards, including China Petroleum & Chemical Corporation. His career spans academia and business, with a focus on economic research and finance.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Cai Hongbin's career began with a strong foundation in academia. He earned a B.A. in Mathematics from Wuhan University in 1988. This was followed by an M.A. in Economics from Peking University in 1991. He furthered his education in the United States, obtaining a Ph.D. in Economics from Stanford University in 1997.

Academic Career and Rise to Success

From 1997 to 2005, Cai taught at the University of California, Los Angeles. He then returned to China, becoming Dean of the Guanghua School of Management at Peking University from December 2010 to January 2017. In June 2017, Cai joined the HKU Business School, becoming Dean in July 2017. His research focuses on economics and finance, including game theory, the Chinese economy, industrial organization, and corporate finance. He has published numerous academic papers in top international journals and was elected as a Fellow of the Econometric Society.

Business Ventures and Key Business Strategies

Cai's wealth comes from his stake in Jiangsu Hengrui Medicine, a major pharmaceutical company in China. He has served as an independent director on the boards of several corporations, including CCB International (Holdings) Limited and China Petroleum & Chemical Corporation.

Philanthropy

Information regarding Cai Hongbin's specific philanthropic activities and the amounts donated is not readily available through search results. More research may be needed to find the information.

Career Milestones

1988

Graduated

Received a B.A. in Mathematics from Wuhan University.

1991

Graduated

Received an M.A. in Economics from Peking University.

1997

Graduated

Obtained a Ph.D. in Economics from Stanford University.

1997-2005

Professor

Taught at the University of California, Los Angeles.

2010-2017

Dean

Served as Dean of Guanghua School of Management, Peking University.

2017-Present

Dean

Dean of the HKU Business School.

Philanthropy & Social Impact

Unknown

Unknown

$XB

Unknown

Business Philosophy & Leadership

Notable Quotes

"Not Available"

Leadership Principles

Intellect

A key value at Guanghua School of Management, emphasizing the importance of knowledge and understanding.

Innovation

A key value, fostering creativity and new ideas.

Integrity

A key value, emphasizing ethical behavior and trustworthiness.

Internationalization

A key value, highlighting global perspectives and collaboration.

Controversies & Challenges

Unknown

Unknown

No controversies found in the search results.